Pancreatic Cancer Research

ResearcherSanford Burnham Prebys Medical Discovery InstituteActive in the last 2 years

David A. Brenner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2573-525X; OpenAlex author ID A5015535660; NIH RePORTER profile ID 6905710. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
1
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 1 paper · 2026: 1 grant

Papers 3

  1. Author Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Co-author DOI 10.1038/s41586-025-09285-4↗
  2. Publisher Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Co-author DOI 10.1038/s41586-023-05920-0↗
  3. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Co-author DOI 10.1038/s41586-022-05169-z↗

Grants 1

  1. Collagen fibers and fragments regulate pancreatic cancer metabolism and growth R01CA285997↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Michael Karin · 3 shared papers, 1 shared grant, 2022–2026 · strength 1.69
  2. Robert F. Schwabe · 3 shared papers, 2022–2025 · strength 0.43
  3. Beicheng Sun · 3 shared papers, 2022–2025 · strength 0.43
  4. Hua Su · 3 shared papers, 2022–2025 · strength 0.43
  5. Christian M. Metallo · 3 shared papers, 2022–2025 · strength 0.43
  6. Andrew M. Lowy · 3 shared papers, 2022–2025 · strength 0.43

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.